Hematology
Cyclin B1 predicts favorable outcomes in patients with follicular lymphoma
Published in Cancer Weekly, May 31st, 2005
According to a study from Sweden, "substantial research has been dedicated to the study of the relationship between genetic mechanisms regulating cell functions in tumors and how those tumors respond to various treatment regimens. Because these mechanisms are still not well understood, we have chosen to study the genetic makeup of 57 tumor samples from patients with follicular lymphoma (FL)."
"Our goal was to develop a prognostic tool that can be used as an aid in determining FL patients with tumors genetically predisposed to a successful treatment with the CHOP...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2005-05-31)
More Articles from Cancer Weekly
- Apoptosis
Citrus limonoids induced apoptosis in human neuroblastoma cells - Genetics & Genomics
Genetic alterations implicated in accelerated aging syndromes - Leukemia
Causes of death in childhood acute lymphoblastic and myeloid leukemia defined - Lung Cancer
Link between lung cancer and radon in small areas across Scotland examined - Skin Cancer
News coverage focusing on skin cancer prevention and detection found lacking - Abdominal Cancer
Internal and externals markers correlated with abdominal tumor motion - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
